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A novel approach for assessing 
neuromodulation using phase-
locked information measured with 
TMS-EEG
Eri Miyauchi1, Masayuki Ide  2, Hirokazu Tachikawa2, Kiyotaka Nemoto2, Tetsuaki Arai2 & 
Masahiro Kawasaki1
Neuromodulation therapies such as electroconvulsive therapy (ECT) are used to treat several 
neuropsychiatric disorders, including major depressive disorder (MDD). Recent work has highlighted 
the use of combined transcranial magnetic stimulation and electroencephalography (TMS-EEG) to 
evaluate the therapeutic effects of neuromodulation; particularly, the phase locking factor (PLF) and 
phase locking value (PLV) can reportedly assess neuromodulation-induced functional changes in cortical 
networks. To examine changes in TMS-induced PLV and PLF before and after ECT, and their relationship 
with depression severity in patients with MDD, TMS-EEG and the Montgomery–Åsberg Depression 
Rating Scale (MADRS; depression severity) were implemented before and after ECT in 10 patients with 
MDD. Single-pulse TMS was applied to the visual and motor areas to induce phase propagation in the 
visuo-motor network at rest. Functional changes were assessed using PLF and PLV data. Pre-ECT TMS-
induced alpha band (9–12 Hz) PLV was negatively correlated with depression severity, and increments 
of post-ECT from pre-ECT TMS-induced alpha band PLV were positively correlated with the reduction 
in depression severity. Moreover, we found a negative correlation between pre-ECT TMS-induced PLF 
at TMS-destination and depression severity. Finally, differences in post-ECT TMS-induced PLF peak 
latencies between visual and motor areas were positively correlated with depression severity. TMS-EEG-
based PLV and PLF may be used to assess the therapeutic effects of neuromodulation and depressive 
states, respectively. Furthermore, our results provide new insights about the neural mechanisms of ECT 
and depression.
Neuromodulatory techniques, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct 
current stimulation (tDCS), and electroconvulsive therapy (ECT)1, have been used for the treatment of several 
neurological and psychiatric disorders, including Parkinson’s disease2, schizophrenia3, and major depressive dis-
order (MDD)4,5. Although the exact mechanisms of these techniques are not yet fully understood, it is thought 
that neuromodulation regulates functional disturbances in relevant distributed neural circuits6 by inducing elec-
tric currents that lead to plastic reorganisation of cortical circuits7. ECT has long been considered to be highly 
effective for treating depression8,9, which has been associated with abnormal functional connectivity10. Some 
studies have argued that ECT modulates the EEG complexity11,12 and the functional connectivity in functional 
magnetic resonance imaging13,14. However, the neural mechanisms of both ECT and depression remain unclear. 
It is thus important to evaluate the therapeutic effects of neuromodulation using precise methods that capture 
neuromodulation-induced functional changes.
In recent years, the combination of TMS with electroencephalography (EEG) (hereafter called TMS-EEG) 
has been used to evaluate the electrophysiological effects of neuromodulatory techniques. Application of TMS 
pulses enables direct perturbation of cortical regions, and simultaneous EEG recording allows the immediate 
electrophysiological responses of the stimulated neurons to be measured15,16. In particular, TMS is considered as 
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an event or a sensory stimulus for conventional event-related potential paradigms in EEG experiments17. Thus, 
unlike experiments with EEG alone, TMS-EEG allows changes in input parameters and/or stimulation to be 
closely controlled, which means that more accurate evaluations can be made.
TMS-EEG paradigms have been employed to measure the effect of neuromodulation on the cortex by quan-
tifying changes in motor evoked potentials (MEPs) elicited from the motor cortex17 and TMS-evoked poten-
tials (TEPs) elicited from non-motor cortical regions16. For example, changes in MEP amplitudes in response to 
single-pulse TMS of controlled intensity are thought to provide an index of rTMS-induced neuroplasticity of the 
motor cortex17–19. Although MEPs can be easily recorded and analysed20, these are influenced by non-cortical 
confounds such as spinal cord excitability16. Moreover, because the exact neural mechanism of neuromodulation 
is not yet fully understood, it is not clear whether MEP changes accurately monitor neuromodulation-induced 
neuroplasticity.
On the other hand, TEP-based measures are not influenced by non-cortical confounds16 and can be 
used to analyse the whole brain effect of neuromodulation. For example, analysis of TEP amplitudes allows 
local responses to neuromodulation to be assessed21, and calculations of coherence from TEPs allow global 
neuromodulation-induced changes to be assessed22. However, analysing amplitudes is not an ideal approach to 
assess the effects of neuromodulation therapies, because these are primarily used to treat psychiatric patients who 
already exhibit large individual differences in brain activity10,23; furthermore, this approach requires a baseline 
normalisation prior to analysis. Instead, phase, which is calculated by time-frequency analysis, does not require 
normalisation and can uniformly assess the temporal dynamics of TMS-induced brain activity. Therefore, this 
approach can be used to assess network connectivity of not only local synchronisation under a single electrode, 
but also global synchronisation between two distant electrodes, and with a high temporal resolution.
In recent years, it has been suggested that TMS-induced oscillations reflect phase resetting of on-going cortical 
oscillations24. Recent TMS-EEG studies have suggested that single-pulse TMS can induce transient neural oscilla-
tions in several frequency bands in different cortical areas of the human brain25–28. Kawasaki et al.24 demonstrated 
the effect of single-pulse TMS-induced phase resetting across the brain by calculating the phase locking factor 
(PLF), which is an index of phase-locking of the oscillatory activity on an electrode across trials29. Their approach 
allowed the intensity of information flow through a cortical network to be defined, as well as the causal and direc-
tional flow of information, which was identified to flow from visual to motor areas24. In addition, Miyauchi et al.30 
found that phase locking value (PLV), a measure of the intensity of phase synchronies between two electrodes31, 
can be used to evaluate the propagation effect of single-pulse TMS-induced phase resetting within a functional 
network relevant with working memory.
The purpose of this study was to explore the relationship between the TMS-induced changes in PLV and 
PLF and clinical changes of depression induced by ECT in patients with MDD. This study has focused on the 
visuo-motor network as the stimulation target because the directionality of information flow in the network has 
been defined24 and the visuo-motor connectivity has been reported to reflect the decrement in visuo-motor per-
formance in depression32. Therefore, TMS was applied to visual and motor areas (i.e. targeting the visuo-motor 
network) to induce phase propagation before and after ECT. Functional changes were calculated using PLF and 
PLV measures, and ECT-induced clinical changes were measured using the Montgomery–Åsberg Depression 
Rating Scale (MADRS)33.
Materials and Methods
Participants. Ten patients (five men and five women aged 27–77 years; mean age: 54.5 years) with MDD 
completed all experiments. Diagnoses of major depressive disorder were established according to the Diagnostic 
and Statistical Manual of Mental Disorders (5th edition)34 criteria by experienced psychiatrists. Disease sever-
ity was evaluated using MADRS within 1 day prior to the first ECT session and 1 day after the ECT session. 
Psychiatrists interviewed each patient for scoring MADRS. Disease severity was evaluated using the MADRS 
within 1 day prior to the first ECT session and 1 day after the ECT session. Moreover, dementia was evaluated 
using the Mini-Mental State Examination (MMSE)35. Patients were being treated with antidepressants, antipsy-
chotics, anticonvulsants, and/or benzodiazepines. During the experiments, antidepressant treatments were not 
altered, but anti-psychotic intake was altered in one patient and benzodiazepines were altered in two patients. 
Eight patients were ECT-naïve and two patients (Patients 3 and 8) were administered ECT for maintenance. All 
patients gave written informed consent before participation. The study was approved by the Faculty of Medicine 
and Medical Sciences, Research Ethics Committee of the University of Tsukuba and was in accordance with the 
Declaration of Helsinki.
ECT procedure. Brief pulse, constant current, square wave ECT (Thymatron System IV, Somatics Inc., Lake 
Bluff, IL, USA) was administrated two or three times a week with bilateral electrode placement. The half-age 
method36 was used for determining energy intensity of the first session, and intensity was then increased by 
10–20% in each subsequent session to elicit adequate seizures. Adequate seizures with 100% energy intensity 
could not be elicited in one patient (Patient 5), and so a sine-wave device (CS-1, SAKAI Medical Co., Ltd., Tokyo, 
Japan) was used for ECT (110–120 V, 7 seconds) from the 2nd to 6th sessions. Anaesthesia was induced by thi-
amylal, and succinylcholine was administrated for muscle relaxation. Nicardipine was administrated to prevent 
excessive hypertension. The number of ECT sessions varied among patients according to the severity of the dis-
ease or responses to ECT.
TMS. TMS-EEG was measured within 1 day prior to the first ECT session and 1 day after the ECT session. 
Each participant completed two separate sessions (corresponding to visual-TMS and motor-TMS conditions) 
before and after ECT. The order of conditions was counterbalanced across participants. Each session consisted of 
40 TMS applications. Single-pulse TMS was delivered to the respective brain area at jittered time intervals that 
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ranged from 2.5 to 6.5 s (0.5 s steps) and each session lasted for 3 min. TMS sessions were conducted in a dimly lit 
electronic- and sound-shielded room. During sessions, participants sat in a chair, rested their chin on a chin-rest, 
and closed their eyes. Participants wore earplugs to help attenuate the effects of TMS-related noise.
TMS was delivered through a figure-of-eight coil with a 70-mm wing diameter that was connected to a bipha-
sic stimulator (Magstim Rapid MRS1000/50, Magstim Company Ltd., UK). We used the flexible arm of a camera 
stand to fix the coil at the same position and direction for the duration of each session. TMS intensity was fixed 
to 0.79 Tesla. This intensity was close to 95% of the averaged motor threshold across participants found in our 
previous study24. When delivering TMS to the visual areas, we fixed the TMS coil over the occipital pole (over the 
Oz electrode) with the handle oriented upward. In contrast, when delivering TMS to the motor areas, we placed 
the TMS coil tangential to the scalp, with the handle pointing 45° posterolaterally over the central left area (over 
the C3 electrode).
EEG recording. Continuous EEG was recorded from 27 scalp electrodes (Ag/AgCl) embedded in a 
TMS-compatible electrode cap (EasyCap; EASYCAP GmbH, Herrsching, Germany) in accordance with the 
extended version of the International 10–20 system. EEG data were recorded and amplified using BrainAmp 
MR+ apparatus (Brain Products, Munich, Germany) at a sampling rate of 1000 Hz. Reference electrodes were 
placed on the left and the right mastoids and were virtually connected.
We focused on the vicinity of the C3 and Oz electrodes as the left motor and visual areas, because our previous 
study clearly showed transitions of the TMS-evoked PLF changes from the Oz to the C3 electrodes24. Moreover, 
we stimulated in the vicinity of these areas under the motor and visual TMS conditions. Therefore, this study only 
examined the synchronisation between motor and visual areas and the information transmission from motor to 
visual areas or from visual to motor areas.
EEG pre-processing. EEG data were segmented into 3-s epochs (from 1-s pre-TMS to 2-s post-TMS). To 
reduce TMS-related artifacts, we removed the EEG data from −1 to 7 ms from TMS onset using linear inter-
polation, according to previous studies24,37. The EEG data were bandpass filtered (0.1–30 Hz). Electrode ampli-
tudes exceeding ±100 µV during the 100 ms before stimulus onset and the 400 ms after onset were considered to 
indicate the presence of ocular artifacts (i.e. eye movements) and corresponding trials were removed from the 
analysis.
EEG analysis. EEG data were analysed using MATLAB software. Time-frequency phases were calculated 
with wavelet transforms using Morlet’s wavelets function w(t, f0)29. Morlet’s wavelets w(t, f0) have a Gaussian 
shape both in the time domain (SD σt) and in the frequency domain (SD σf) around their central frequency f0. 
The following formula was used to calculate Morlet’s wavelets.
σ pi σ pi
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We used a wavelet that was characterised by a constant ratio (f ⁄σf = 5), with f ranging from 1–20 Hz (1-Hz steps). 
The time-frequency phases were segmented into the three following frequency bands: theta (4–7 Hz), alpha 
(8–12 Hz), and beta (13–20 Hz). We used the PLV to identify the TMS-evoked phase synchronisation between 
visual and motor electrodes. The PLV for an electrode pair (ei, ej), time point (t), and frequency (f) was calculated 
as follows:
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where φ is the instantaneous phase of EEG data and N is the total number of epochs included in the calculation.
In contrast, we used the PLF to identify the TMS-evoked phase resetting at each electrode. The PLF for an 
electrode (ei) was calculated as follows:
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Statistical analysis. Within-group comparisons of MADRS scores (pre- vs. post-ECT) were performed 
using paired t-tests. Moreover, the relationships between the EEG results (i.e., PLV or PLF) and MADRS scores 
were analysed using Pearson’s correlation coefficient. We used the statistics toolbox on MATLAB software 
(R2015b, Mathworks Inc., Natick, MA, USA) to perform all statistical analyses.
Results
Clinical effect of ECT. The demographic information of patients is shown in Table 1. All patients had been 
diagnosed with MDD prior to experiments, and included those with partial and full remission. All patients 
showed higher MMSE scores than the cut-off point (23/24) for cognitive impairment, which suggests that any 
individual differences in TMS-EEG results were not due to the effects of cognitive impairment.
Pre-ECT, five patients (Patients 1–5) showed MADRS scores of over 20, which is cut-off point for moderate 
depression. Of these, Patient 1 had a score over 35, which is cut-off point for severe depression. In contrast, all 
patients had post-ECT MADRS scores under 20. Seven patients appeared to benefit from ECT, as indicated by a 
reduction of MADRS scores post-ECT compared to pre-ECT. While this difference in MADRS scores (pre-ECT 
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vs. post-ECT) was not significant, we nonetheless observed a strong trend for lower MADRS scores after ECT 
(pre-ECT = (mean ± s.e.m.) 19.50 ± 4.51; post-ECT = 9.00 ± 2.06; paired t-tests, t = 2.075, p < 0.053).
PLV in visual-TMS conditions. To measure global synchronisation of the visuo-motor network, we calcu-
lated the PLV between visual and motor areas. The individual time-frequency PLVs between motor and visual 
areas for pre-ECT and post-ECT sessions are shown in Fig. 1A.
Post-ECT, all patients showed transient enhancements of visuo-motor PLVs ranging from 1 to 20 Hz at around 
TMS onset. These enhancements were observed ahead of TMS onsets because of the wavelet time resolution. 
Low-frequency PLVs, especially alpha bands (9–12 Hz), increased from TMS onsets.
Pre-ECT, enhancements of PLVs ranging from 1 to 20 Hz were not observed in the five patients with high 
MADRS scores. In contrast, the five patients with low MADRS scores showed transient enhancements of 
low-frequency PLV (i.e. alpha PLV) at both pre-ECT and post-ECT.
Next, we calculated the maximum alpha PLVs within a latency window of −500 ms to 500 ms from TMS 
onset. These were significantly and negatively correlated with MADRS scores at pre-ECT (r = −0.704, p < 0.024), 
but not at post-ECT (r = 0.182, p = 0.615; Fig. 2A). This correlation was still significant after excluding the three 
patients (ID:5, 6, 9) whose drugs were altered during the experiments (r = −0.757, p < 0.048). Moreover, the 
differences in alpha PLVs between pre- and post-ECT were significantly and negatively correlated with differ-
ences in MADRS scores between the pre- and post-ECT (Fig. 2A; r = −0.782, p < 0.007). This correlation was 
still significant after excluding the three patients (ID:5, 6, 9) whose drugs were altered during the experiments 
(r = −0.808, p < 0.028).
PLF in visual-TMS conditions. We used the visual (TMS-targeted area) and motor (TMS-distant area) 
PLFs to measure local synchronisation ability and network-mediated local synchronisation ability (i.e., trans-
mission intensity), respectively. The individual time-frequency PLFs on motor and visual areas at pre-ECT and 
post-ECT in visual-TMS conditions are shown in Fig. 1B,C. All patients showed transient enhancements of PLFs 
of visual areas that ranged from 1 to 20 Hz, especially in alpha bands, at around the onset of the TMS at both pre- 
and post-ECT. These enhancements were particularly strong at post-ECT.
In contrast, the PLFs of motor areas showed no or small alpha transient enhancements in patients with high 
pre-ECT MADRS scores. However, patients with low pre-ECT MADRS scores showed high alpha PLF enhance-
ments of motor areas. Post-ECT, most patients (all but Patient 5) showed alpha PLF enhancements of motor as 
well as visual areas.
The maximum values of the alpha PLF (within the latency window −500 ms to 500 ms from TMS onset) of 
motor areas were significantly and negatively correlated with MADRS scores at pre-ECT (r = −0.907, p < 0.001), 
but not at post-ECT (r = 0.086, p = 0.813). This correlation was still significant after excluding the three patients 
(ID:5, 6, 9) whose drugs were altered during the experiments (r = −0.951, p < 0.001). In contrast, the maximum 
values of alpha PLFs of visual areas were not correlated with MADRS scores at either pre-ECT (r = −0.527, 
p = 0.118) or post-ECT (r = 0.549, p = 0.100). Individual motor and visual PLF data are shown in Fig. 2B,C. 
Moreover, the differences in alpha motor PLFs between the pre- and post-ECT were significantly and negatively 
correlated with differences in MADRS scores between pre- and post-ECT (Fig. 2B; r = −0.911, p < 0.001). No 
such correlation was observed for alpha visual PLFs (r = −0.427, p = 0.218).
The above results suggested that information transfers from the visual to motor areas post-ECT, but not 
pre-ECT. Therefore, we calculated the differences in maximum PLF values and their peak latencies from TMS 
onset between visual and motor areas. We considered the differences in peak latencies of maximum TMS-induced 
PLF appearances between visual and motor areas to reflect the speed of information transmission within the 
network. Differences in maximum PLF values were not correlated with MADRS scores (Fig. 3A; r = 0.035, 
p = 0.925). However, the time differences of PLF peak latencies were significantly and positively correlated with 
MADRS scores (Fig. 3B; r = 0.778, p < 0.008).
ID Age Sex Disease MMSE
MADRS 
(pre-ECT)
MADRS 
(post-ECT) ΔMADRS
No. 
ECT
medication (dose 
alteration)
1 77 Female MDD 25 49 17 32 8 d
2 27 Male MDD 28 30 5 25 4 d,p,b
3 74 Female MDD 27 20 5 15 2 d,b
4 54 Female MDD 29 27 15 12 6 p,b
5 68 Male MDD 26 24 14 10 6 p (risperidone 1 mg)
6 27 Male MDD 30 15 9 6 5 p,b (etizolam 0.5 mg↓)
7 43 Male partial remission 30 6 0 6 6 d, p
8 69 Female full remission 30 0 0 0 2 d, p,b
9 42 Male MDD 30 16 17 −1 10 p,b,c (flunitrazepam 1 mg↓)
10 64 Female MDD, OCD 29 6 8 −2 6 d, b
Table 1. Individual patient demographics. d: antidepressants, p: antipsychotics, b: benzodiazepines, c: 
anticonvulsants.
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PLV and PLF in motor-TMS conditions. We conducted the same PLV and PLF analyses for the motor-TMS 
condition to investigate their relationship with MADRS scores. Most patients showed no transient enhancements 
of visuo-motor PLVs ranging from 1 to 20 Hz at around the onset of TMS for either pre- or post-ECT time points. 
Moreover, there were no correlations between the maximum values of alpha PLV and MADRS scores at either 
pre-ECT (r = −0.331, p = 0.351) or post-ECT sessions (r = 0.287, p = 0.422; Fig. 4A).
For PLFs of the motor areas (i.e. the TMS-targeted areas), most patients showed transient enhancements 
ranging from 1 to 20 Hz, especially in alpha bands, at around the onset of TMS at both pre- and post-ECT. 
However, these enhancements were not correlated with MADRS scores at either pre-ECT (r = 0.397, p = 0.255) 
or post-ECT (r = −0.291, p = 0.415; Fig. 4B). The PLF of visual areas showed no transient enhancements and 
no correlation with MADRS scores at either pre-ECT (r = −0.216, p = 0.550) or post-ECT (r = 0.099, p = 0.786; 
Fig. 4C).
The differences of alpha PLVs and PLFs between pre- and post-ECT also showed no correlation with the dif-
ferences in MADRS scores between the pre- and post-ECT (PLV: r = −0.222, p = 0.539; PLF on motor: r = 0.172, 
p = 0.634; PLF on visual: r = 0.183, p = 0.612).
Figure 1. PLV and PLF in visual-TMS conditions. (A) Individual time-frequency PLV between motor and 
visual areas and (B,C) time-frequency PLF on motor and visual areas in pre-ECT and post-ECT sessions. The 
individual MADRS scores at pre-ECT and post-ECT are shown as the left and right numbers below the patient 
number, respectively.
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Figure 2. PLV and PLF in visual-TMS conditions. (A) Scatter plots between MADRS scores and (A) visuo-
motor alpha PLV, (B) alpha motor PLF, and (C) alpha visual PLF, in the pre-ECT (left) and post-ECT (centre) 
sessions. Scatter plots shown in panels on the right show the differences in MADRS scores and differences in 
PLV/PLF between pre- and post-ECT.
Figure 3. Visual-TMS conditions. (A) Scatter plots between MADRS scores and PLF values between visual and 
motor areas post-ECT. (B) Scatter plots between MADRS scores and differences in PLF peak latencies between 
visual and motor areas post-ECT.
www.nature.com/scientificreports/
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Discussion
In this study, we aimed to investigate whether PLV and PLF can be used to assess depression severity and the 
ECT-induced functional changes in MDD. The intensity of phase synchronies/propagation within the net-
work was evaluated using PLV, and the intensity and direction of information flow was evaluated using PLF. To 
this end, we computed the following parameters: (1) TMS-induced PLVs between visual and motor areas, (2) 
TMS-induced PLF at visual and motor areas, (3) differences in transmission intensities of TMS-induced PLF 
between visual and motor areas, and (4) differences in TMS-induced PLF peak latencies between visual and 
motor areas. We then analysed whether those parameters differed before and after ECT, and how these changes 
were associated with the ECT-induced changes in depression severity.
PLV for ECT/depression assessment and mechanism. The most interesting finding was that pre-ECT 
TMS-induced PLV was negatively correlated with depression severity, and that pre-post changes in TMS-induced 
PLV were positively correlated with the reduction in depression severity. This indicates that the pre-post change in 
TMS-induced PLV can be used to assess the antidepressant effects of ECT, and, more generally, that TMS-induced 
PLV can be used to evaluate depressive states. Moreover, these correlations were strongest in the alpha band 
frequency, which suggests that the inter-areal alpha synchrony of the visuo-motor network is decreased dur-
ing MDD, and increased by ECT. These results agree with previous findings that the larger increase in cortical 
excitability induced by 10-Hz rTMS predicts a greater reduction in depressive symptoms after therapeutic neu-
romodulation38. Furthermore, our results further support the idea that depression is associated with a decrease 
in functional network connectivity at resting state10. However, it is somewhat surprising that the results were not 
best described at the theta frequency band, as was found by previous related studies24,30. This may be due to the 
small number of trials and a consequently limited statistical power. Interestingly, the PLV changes were smaller 
when the severity of depression was moderate to high, which suggests that ECT-induced alterations of the net-
work only occur in more severe cases of depression.
Figure 4. Motor-TMS conditions. (A) Scatter plots between MADRS scores and (A) visuo-motor alpha PLV, 
(B) alpha motor PLF, and (C) alpha visual PLF, in the pre-ECT (left) and post-ECT (centre) sessions. Scatter 
plots shown in panels on the right show the differences in MADRS and differences in PLV/PLF between pre- 
and post-ECT.
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PLF (transmission intensity) for depression assessment. We found a negative correlation between 
pre-ECT TMS-induced PLF at the motor area and the severity of depression, which disappeared after ECT. 
The pre-post difference in the correlation is likely to be related to the change in the severity of depression over 
the course of the study. The severity of depression improved remarkably in all subjects after ECT; the sever-
ity of depression pre-ECT ranged from “symptom-free” to “severe”, whereas post-ECT severities ranged from 
“symptom-free” to “mild”. Consistent with our PLV results, it can thus be suggested that ECT-induced network 
alterations are more prominent in patients with moderate or severe symptoms of depression. In addition, the 
transmission intensities of TMS-induced PLF within target networks is useful to assess moderate or higher 
depressive states.
PLF (time difference) for depression assessment. Interestingly, we found that peak differences of 
post-ECT TMS-induced PLFs between visual and motor areas were positively correlated with the severity of 
depression. Such peak differences in PLFs were not detected at pre-ECT, i.e., no propagation effect was found. 
Our analysis of differences in PLF peak latencies is a new approach, and these findings are therefore only pre-
liminary; however, presuming that differences in PLF peak latencies between the two areas indicate the time of 
propagation in the network, these results suggest that an alteration of the network is associated with a decrease 
in the speed of information transmission within the network, and that ECT increases this transmission speed. 
Moreover, this method could be used to evaluate depressive states when there is sufficient propagation within the 
network.
PLF change (local) for mechanism of depression. The TMS-induced PLF at the TMS-targeted 
areas showed no correlation with depression severity, either before or after ECT. This implies that local activities 
of the visual and motor areas are not relevant to depressive states, and that depression is associated with a global 
rather than local dysfunction. These conclusions are consistent with previous findings that a dysfunctional net-
work underlies depression rather than a single brain area10,39.
Visuo-motor network. There was no significant increase in TMS-induced PLV and in TMS-induced PLF at 
the visual area when TMS was targeted to the motor area. Consistent with previous studies24,30, these results indi-
cate that information flows from visual to motor areas. Although the present study was not designed to provide 
new insights about the relationship between visuo-motor functional connectivity and depression, the observed 
dysfunction in visuo-motor connectivity is potentially relevant to findings of impairments of sensory and motor 
processes that are reflected by slowed performance in depression32. We used the visuo-motor network as the stim-
ulation target because this is the only network in which the directionality of information flow has been defined24. 
Future investigations could target different networks that have a more evident relationship with depression, such 
as the subgenual cingulate23. For this, it would be necessary to identify the flow directionality of the functional 
network associated with this area before conducting TMS-EEG to target the network.
Limitations and future work. Firstly, the small sample size and small number of trials meant that it was 
not possible to validate the current results. For example, changes in network propagation may be limited to those 
of whom showed a significant reduction in depression severity. Therefore, in future, larger-scale studies will be 
required for this. Secondly, the present study did not employ a control group for comparison, and so interpre-
tations are limited to patients with MDD. That said, our results are consistent with studies with healthy sub-
jects, which have reported an increase of TMS-induced PLF values at rest24 and increased TMS-induced PLV30. 
Furthermore, it is difficult to implement invasive techniques such as ECT in healthy individuals. However, future 
studies could compare resting data between patients and healthy controls or use non-invasive therapeutic neuro-
modulations. Finally, we did not use a neuronavigation system or individual motor thresholds for target selection. 
Thus, it is possible that TMS-targeted locations were not identical across pre-ECT and post-ECT sessions. Some 
researchers have recommended the use of a navigated TMS to accurately compute the location of coil based on 
individual cortical surface anatomy40, and future studies could consider this. To build an evaluation system using 
TMS-EEG based PLV and PLF for the therapeutic effects of neuromodulations, future studies should address the 
above limitations.
Conclusion
According to our results, pre-post differences in TMS-induced PLV can be used to assess the antidepressant 
effects of ECT, and TMS-induced PLV can be used to evaluate depressive states. Moreover, our results suggest that 
transmission intensities and speed of information transmission calculated from TMS-induced PLF can be used 
to evaluate moderate or higher states of depression. The present findings therefore have a number of important 
clinical implications. Namely, our results suggest that the TMS-induced PLV and PLF approaches can be used to 
assess the therapeutic effects of not only ECT, but also other neuromodulation techniques and medications that 
are used to improve cortical network function. Furthermore, our findings imply that our proposed approach can 
be used to assess depressive states, not only in patients with MDD, but also those with other neuropsychiatric dis-
orders or any clinical condition involving impaired cortical networks. Future research using these TMS-induced 
PLV and PLF approaches will therefore help us to better understand the mechanisms underlying neuropsychiatric 
disorders.
www.nature.com/scientificreports/
9ScIEnTIFIc REpoRTS |           (2019) 9:428  | DOI:10.1038/s41598-018-36317-z
References
 1. Janicak, G., Dowd, S. M., Rado, J. T. & Welch, M. J. The Re-Emerging Role of Therapeutic Neuromodulation. Curr. Psychiatr. 9, 
66–74 (2010).
 2. Kimura, H. et al. A comprehensive study of repetitive transcranial magnetic stimulation in Parkinson’s disease. ISRN Neurol, 845453 
(2011).
 3. Meduna, L. New methods of medical treatment of schizophrenia. Arch Neurol Psychiatry 35, 36–63 (1936).
 4. Leuchter, A. F., Cook, I. A., Jin, Y. & Phillips, B. The relationship between brain oscillatory activity and therapeutic effectiveness of 
transcranial magnetic stimulation in the treatment of major depressive disorder. Front. Hum. Neurosci. 7, 1–12 (2013).
 5. Murphy, D. N., Boggio, P. & Fregni, F. Transcranial direct current stimulation as a therapeutic tool for the treatment of major 
depression: insights from past and recent clinical studies. Curr. Opin. Psychiatry. 22, 306–11 (2009).
 6. Janicak, P. G., Marder, S. R., & Pavuluri, M. N. Principles and practice of psychopharmacotherapy. Lippincott Williams & Wilkins 
(2010).
 7. Wagner, T., Rushmore, J., Eden, U. & Valero-Cabre, A. Biophysical foundations underlying TMS: Setting the stage for an effective 
use of neurostimulation in the cognitive neurosciences. Cortex 45, 1025–34 (2009).
 8. Bolwig, T. G. How does electroconvulsive therapy work? Theories on its mechanism. Can. J. Psychiatry. 56, 13–18 (2011).
 9. American Psychiatric Association. Task Force on Electroconvulsive Therapy. The practice of electroconvulsive therapy: 
recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Association (2001).
 10. Veer, I. M. et al. Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Front. Syst. 
Neurosci. 4, 1–10 (2010).
 11. Okazaki, R. et al. Effects of electroconvulsive therapy on neural complexity inpatients with depression: report of three cases. J. Affect. 
Disord 150, 389–392 (2013).
 12. Farzan, F. et al. Brain temporal complexity in explaining the therapeutic and cognitive effects of seizure therapy. Brain 140, 
1011–1025 (2017).
 13. Beall, E. B. et al. Effects of electroconvulsive therapy on brain functional activation and connectivity in depression. J ECT 28, 
234–4110 (2012).
 14. Abbott, C. C. et al. Electroconvulsive therapy response in major depressive disorder: a pilot functional network connectivity resting 
state FMRI investigation. Front. Psychiatry. 4, 10.10.3389 (2013).
 15. Casarotto, S. et al. Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic 
stimulation and electroencephalography. Brain Topogr. 26, 326–337 (2013).
 16. Chung, S. W., Rogasch, N. C., Hoy, K. E. & Fitzgerald, P. B. Measuring brain stimulation induced changes in cortical properties using 
TMS-EEG. Brain Stimul. 8, 1010–20 (2015).
 17. Farzan, F. et al. Characterizing and Modulating Brain Circuitry through Transcranial Magnetic Stimulation Combined with 
Electroencephalography. Front. Neural. Circuits. 10.73 (2016).
 18. Fitzgerald, P. B., Fountain, S. & Daskalakis, Z. J. A comprehensive review of the effects of rTMS on motor cortical excitability and 
inhibition. Clin. Neurophysiol. 117, 2584–2596 (2006).
 19. Thut, G. & Pascual-Leone, A. A review of combined TMS-EEG studies to characterize lasting effects of repetitive TMS and assess 
their usefulness in cognitive and clinical neuroscience. Brain Topogr. 22, 219–232 (2010).
 20. Kapogiannis, D. & Wassermann, E. M. Transcranial magnetic stimulation in Clinical Pharmacology. Cent. Nerv. Syst. Agents. Med. 
Chem. 8, 234–40 (2008).
 21. Canali, P. et al. Changes of cortical excitability as markers of antidepressant response in bipolar depression: Preliminary data 
obtained by combining transcranial magnetic stimulation (TMS) and electroencephalography (EEG). Bipolar Disord. 16, 809–819 
(2014).
 22. Pascual-Leone, A. et al. Characterizing brain cortical plasticity and network dynamics across the age-span in health and disease with 
TMS-EEG and TMS-fMRI. Brain Topogr. 24, 302–315 (2011).
 23. Broyd, S. J. et al. Default-mode brain dysfunction in mental disorders: A systematic review. Neurosci. Biobehav. Rev. 33, 279–296 
(2009).
 24. Kawasaki, M., Uno, Y., Mori, J., Kobata, K. & Kitajo, K. Transcranial magnetic stimulation-induced global propagation of transient 
phase resetting associated with directional information flow. Front. Hum. Neurosci. 8, 173 (2014).
 25. Paus, T., Sipila, P. K. & Strafella, A. P. Synchronization of neuronal activity in the human primary motor cortex by transcranial 
magnetic stimulation: an EEG study. J. Neurophysiol. 86, 1983–1990 (2001).
 26. Fuggetta, G., Fiaschi, A. & Manganotti, P. Modulation of cortical oscillatory activities induced by varying single-pulse transcranial 
magnetic stimulation intensity over the left primary motor area: A combined EEG and TMS study. Neuroimage 27, 896–908 (2005).
 27. Van Der Werf, Y. D. & Paus, T. The neural response to transcranial magnetic stimulation of the human motor cortex. I. Intracortical 
and cortico-cortical contributions. Exp. Brain Res. 175, 231–245 (2006).
 28. Thut, G. & Miniussi, C. New insights into rhythmic brain activity from TMS–EEG studies. Trends Cogn. Sci. 13, 182–189 (2009).
 29. Tallon-Baudry, C., Bertrand, O., Delpuech, C. & Pernier, J. Stimulus specificity of phase-locked and non-phase-locked 40 Hz visual 
responses in human. J. Neurosci. 16, 4240–4249 (1996).
 30. Miyauchi, E., Kitajo, K. & Kawasaki, M. TMS-induced theta phase synchrony reveals a bottom-up network in working memory. 
Neurosci. Lett. 622, 10–14 (2016).
 31. Lachaux, J. P., Rodriguez, E., Martinerie, J. & Varela, F. J. Measuring phase synchrony in brain signals. Hum. Brain Mapp. 8, 194–208 
(1999).
 32. Zarrinpar, A., Deldin, P., Kosslyn, S. M. & Deldin, P. Effects of depression on sensory/motor vs. central processing in visual mental 
imagery. Cogn. Emot. 20, 737–758 (2006).
 33. Montgomery, S. A. & Asberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382–389 (1979).
 34. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.) (2013).
 35. Folstein, M. F., Folstein, S. E. & McHugh, P. R. Mini-mental state. J. Psychiatr. Res. 12, 189–198 (1975).
 36. Petrides, G. & Fink, M. The “half-age” stimulation strategy for ECT dosing. Convuls. Ther. 12, 138–146 (1996).
 37. Veniero, D., Bortoletto, M. & Miniussi, C. TMS-EEG co-registration: On TMS-induced artifact. Clin. Neurophysiol. 120, 1392–1399 
(2009).
 38. Oliveira-Maia, A. J., Press, D. & Pascual-Leone, A. Modulation of motor cortex excitability predicts antidepressant response to 
prefrontal cortex repetitive transcranial magnetic stimulation. Brain Stimul. 10, 787–794 (2017).
 39. Davidson, R. J., Pizzagalli, D., Nitschke, J. B. & Putnam, K. Depression: Perspectives from Affective Neuroscience. Annu. Rev. 
Psychol. 53, 545–574 (2002).
 40. Ilmoniemi, R. J. & Kičić, D. Methodology for combined TMS and EEG. Brain Topogr. 22, 233–248 (2010).
Acknowledgements
The research was supported by a Grant-in-Aid for Scientific Research on Innovative areas (15H01576) and the 
Program to Disseminate Tenure Tracking System MEXT.
www.nature.com/scientificreports/
1 0ScIEnTIFIc REpoRTS |           (2019) 9:428  | DOI:10.1038/s41598-018-36317-z
Author Contributions
E.M. and M.K. designed the study, performed EEG experiments, analyzed behavioral and EEG data, and wrote 
the paper; M.I., H.T., K.N. and T.A. performed assessments, supported experiments and analyses, and discussed 
the data.
Additional Information
Competing Interests: The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
